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similar  to  other  metazoan  pathogens,  Schistosoma  mansoni  undergoes  transcriptional  and 
developmental regulation during its complex lifecycle and host interactions. DnA methylation 
as a mechanism to control these processes has, to date, been discounted in this parasite. Here 
we show the first evidence for cytosine methylation in the S. mansoni genome. Transcriptional 
coregulation of novel DnA methyltransferase (smDnmt2) and methyl-CpG-binding domain 
proteins mirrors the detection of cytosine methylation abundance and implicates the presence 
of a functional DnA methylation machinery. Genome losses in cytosine methylation upon 
smDnmt2  silencing  and  the  identification  of  a  hypermethylated,  repetitive  intron  within  a 
predicted  forkhead  gene  confirm  this  assertion.  Importantly,  disruption  of  egg  production 
and  egg  maturation  by  5-azacytidine  establishes  an  essential  role  for  5-methylcytosine  in   
this  parasite.  These  findings  provide  the  first  functional  confirmation  for  this  epigenetic 
modification in any worm species and link the cytosine methylation machinery to platyhelminth 
oviposition processes. 
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S
chistosomiasis is one of the most important neglected tropi-
cal diseases afflicting humans, when viewed in terms of its 
prevalence, negative impact on disability adjusted life years   
(a metric for measuring morbidity)1 and annual mortality rates2. 
More than 200 million people suffer from this chronic and debili-
tating disease, with 90% of all worldwide cases arising in poverty-
stricken areas of sub-Saharan Africa3. Praziquantel is the current 
drug of choice to treat schistosomiasis, but the need for repetitive 
treatment in endemic communities, concerns over the emergence 
of drug resistance and an unknown mechanism of action4 have all 
catalysed an urgent search for new chemotherapeutic agents.
Three  major  blood  fluke  species  within  the  phylum  Platy-
helminthes, genus Schistosoma (S. japonicum, S. haematobium and 
S. mansoni), cause schistosomiasis in humans. Largely restricted 
to Africa, South America, the Middle East and the West Indies,   
S. mansoni infection is initiated when humans are exposed to fresh 
water harbouring free-swimming cercariae. On percutaneous inva-
sion of the definitive human host, schistosomes undergo complex 
developmental reprogramming necessary for survival in a hostile 
new environment, as well as to facilitate migration to the vascula-
ture surrounding the bowels. Notable characteristics of this process 
include the complete transformation of surface membranes5, the 
dependence on haematophagy as a major energy source, the selec-
tive de novo expression of several hundred gene products6 and the 
differentiation into morphologically and transcriptionally distinct 
adult male and female pairs7 capable of producing hundreds of eggs 
every day. The host’s immune response and microspines covering 
the eggshell surface facilitate the transendothelial passage of eggs 
into the intestinal lumen from where they are released with faeces. 
On contact with fresh water, the eggs hatch into ciliated miracidia 
capable of locating and infecting a suitable intermediate snail host 
(genus Biomphalaria). Within the snail, miracidia shed their cili-
ated plates and develop into asexually reproducing sporocysts that 
ultimately release human-infective cercariae. Unfortunately, many 
of the eggs produced in the human host remain trapped in the 
intestinal wall or are swept back into the liver where they provoke 
a vigorous immune-mediated, circumoval granulomatous response 
resulting in peri-portal and hepatic fibrosis. It is the collective effect 
of these egg-induced reactions that, almost exclusively, lead to the 
development of pathology, morbidity and mortality associated with 
infection. Understanding the molecular mechanisms underpinning 
schistosome developmental maturation into egg-laying adult worm 
pairs are consequently of paramount importance in our search for 
novel anthelmintic targets, drugs and strategies.
In the only previous study surveying for DNA methylation in 
S. mansoni, Fantappie et al.8 did not detect any evidence for either 
adenine  or  cytosine  methylation.  This  finding  was  surprising  as 
the  schistosome  genome  contains  several  characteristics9  associ-
ated with methylation (for example, under representation of CpG 
sites and composition of 40% repetitive elements). Nevertheless, the 
observations of Fantappie et al. were concordant with several pre-
vious investigations that all failed to identify a functional role for 
DNA methylation in any worm species10. Prima facie, these reports 
imply that DNA methylation does not appear in the schistosome 
genome or feature as a control mechanism during parasite develop-
ment and host interactions. However, there is now growing evidence 
for the presence of DNA methylation in many invertebrates, with 5- 
methylcytosine (m5C) detected in cnidarians (for example, Hydra11), 
molluscs (for example, Donax trunculus11), urochordates (for exam-
ple, Ciona intestinalis12), arthropods (for example, Drosophila mela-
nogaster13),  echinoderms  (for  example,  Echinus  esculentus14)  and 
annelids  (for  example,  Chaetopterus  variopedatus15).  Unlike  the 
developmental roles ascribed for DNA methylation in vertebrates 
(X chromosome inactivation16, allelic exclusion17, gene regulation18, 
embryogenesis19 and repetitive element silencing20), the function of 
this epigenetic regulator at the vertebrate/invertebrate boundary is 
less clearly defined. As schistosomes represent a derived invertebrate 
lineage, any information related to the identification and function 
of DNA methylation within these acoelomate organisms may well 
shed light on its contributory role during early bilateria evolution.
Here we demonstrate that the S. mansoni genome is epigeneti-
cally modified and that parasite developmental maturation is linked 
to quantifiable changes in DNA methylation. Although previous 
studies have failed to identify a functional role for cytosine methyla-
tion in any examined worm species10, we provide evidence that this 
epigenetic modification is found associated with repetitive genomic 
elements and also regulates the important process of schistosome 
oviposition and egg development. It is anticipated that our results 
may provide new targets for schistosomiasis control, as well as fas-
cinating insights into the early events of metazoan evolution by sug-
gesting a critical role for cytosine methylation in the development of 
bilateral symmetry, sexual reproduction and organogenesis.
Results
The  S.  mansoni  genome  is  methylated.  We  used  a  selection 
of  biophysical,  molecular,  immunological  and  cytochemical 
methodologies to survey for the presence of m5C (the most common 
methylated metazoan nucleobase21). This comprehensive approach 
was chosen to minimize false conclusions about the methylation 
status of the schistosome genome, to apply more sensitive techniques 
than used by Fantappie et al.8 and to maximize the certainty of 
detection. Examination of RNA-free, mixed-sex adult schistosome 
genomic  DNA  (gDNA)  using  gas  chromatography  coupled  to 
mass  spectrometry  (GC–MS)  yielded  the  first  evidence  of  m5C 
(m/z = 296.2, retention time = 15.70 min) in this species (Fig. 1a). 
We subsequently extended this observation to other schistosome 
lifecycle  stages  (including  eggs,  miracidia,  sporocysts,  cercariae, 
schistosomula  and  sexually  mature  male  and  female  worms)  by 
employing immunological detection of m5C using enzyme-linked 
immunosorbent assay (ELISA; Fig. 1b). Here, all assayed schistosome 
developmental forms (free from host contamination, for example, 
Mus musculus gDNA) contained detectable, but variable, levels of 
m5C within their genome complements. To further demonstrate 
that  the  detected  schistosome  m5C  was  present  within  nuclear 
compartments, immuno-cytochemical assays (immunolocalization/
genome in situ hybridisation (GISH)) were performed on cytological 
spreads obtained from schistosome infected Biomphalaria glabrata 
snails. Here, m5C was detected in nuclei derived from both the intra-
molluscan sporocyst cells (Sm—blue, red and green nuclei, Fig. 1c)   
and B. glabrata cells (Bg—blue and green nuclei, Fig. 1c). These 
data (m5C positively stained sporocyst nuclei) clearly confirmed 
the ELISA results (Fig. 1b). Moreover, in addition to the central 
S. mansoni observation, immuno-cytochemical detection of m5C 
provided the first evidence for this form of epigenetic modification 
in the intermediate molluscan host, B. glabrata.
We next sought to evaluate whether changes in cytosine methyla-
tion associated with developmental progression could be influenced 
by different environmental challenges. For this, we used a genome-
wide approach, methylation-sensitive amplification polymorphism 
(MSAP)22, to characterize m5C variance between two divergent schis-
tosome lifecycle stages. Principal coordinate analysis (PCA, Fig. 1d, 
dotted versus solid circles) revealed clear separation of MSAP profiles 
between cercariae (water-dwelling) and adult worms (mammalian 
host residing) when parasite gDNA was restricted with methylation-
sensitive HpaII (an enzyme that cannot restrict C5m/CGG) but not 
with the methylation insensitive isoschizomer MspI (an enzyme that 
can restrict C5m/CGG). These data suggested that some of the detected 
genomic m5C (Fig. 1a,b) was found in the context of CpG dinucle-
otide motifs and critically provides evidence that schistosomes alter 
their epigenome in response to different environmental stimuli.
Finally, we extended our global analysis of schistosome DNA 
methylation to the identification of specific genomic loci that are ARTICLE     
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modified by this epigenetic process. Among several cercarial gDNA 
fragments that were isolated by methyl cytosine enrichment, we 
chose to verify the presence of m5C in one particular locus by bisulfite 
conversion, bisulfite PCR and sequencing (Fig. 2). This 316-bp locus 
(NCBI accession number JF781495) mapped to a highly repetitive 
intragenic intron within a predicted forkhead protein, Smp_155010 
(Fig.  2a).  Particular  features  of  this  methylated  locus  included 
a  higher-than-genome-,  scaffold  (scaff000180)-  or  gene  (Smp_
155010)-%GC average (Fig. 2b) and detectable m5C in the context 
of CpG and CpA (Fig. 2c). Although detection of CpG methylation 
confirmed the MSAP studies (Fig. 1d), CpA methylation represents 
an additional feature of the schistosome epigenome. CpA dinucle-
otide motifs are also found methylated in other invertebrate spe-
cies (for example, D. melanogaster23) and suggest that the diversity 
of DNA methylation targets within the schistosome genome is not 
restricted to the CpG context. Importantly, the hypermethylation of 
a repetitive DNA element may indicate that the schistosome DNA 
methylation machinery has evolved to help silence or destroy these 
highly prevalent (and sometimes transcribed24) parasitic genomic 
features  as  previously  demonstrated  in  D.  melanogaster25  and   
Dictyostelium discoideum26,27. Complete sequencing of the schisto-
some epigenome will shed light on this hypothesis.
DNA methylation components are coregulated in development. 
Having provided mutually supportive confirmation for the pres-
ence of m5C (in the context of CpG and CpA dinucleotide motifs), 
we next interrogated the current S. mansoni genome assembly28 
for putative DNA methylation machinery components. Using the   
M.  musculus  DNA  methyltransferase  (Dnmt)  2  amino-acid 
sequence  (AF0458899)  as  a  query,  we  identified  a  single  candi-
date  S.  mansoni  DNA  methyltransferase  (Smp_145390;  the  only 
genome hit with E value  < 1e − 5) following BLASTp analysis of the 
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Figure 1 | Schistosoma mansoni contains a methylated genome. (a) GC–ms identification of m5C from mixed-sex, adult schistosome gDnA (compared 
with m5C standard). selective ion-monitoring (m/z = 296.2) by ms confirmed the presence of m5C in schistosome gDnA (right panel), which 
corresponded to an eluted GC peak at 15.7 min (left and middle panel). (b) ELIsA detection of m5C across the schistosome lifecycle. Histograms ( + , s.d.) 
represent mean m5C abundance (n = 2 for each lifecycle stage), which was normalized (to both positive and negative control DnA samples). Data are 
representative of two independent experiments. Inset: agarose gel illustrates that schistosome gDnA isolated from life stages resident in the definitive 
host (E, egg; Am, adult male; AF, adult female) were not contaminated by M. musculus (mm) gDnA. Primers designed to amplify M. musculus (mm) 
catalase (653 bp product, solid arrow, nCBI accession number X52108.1) and S. mansoni (sm) Venom Allergen Like (VAL) 2 (291 bp product, dashed 
arrow, nCBI accession number AY994062.1) were used. ( − ) represents PCR conditions when no gDnA was included and mW represents molecular 
weight standards. (c) m5C immunolocalization/GIsH analysis of cytological spreads derived from S. mansoni (sm) infected B. glabrata (Bg) snails. Anti-
mouse m5C (IgG1) and isotype control (murine IgG1) primary antibodies were detected by Alexa Fluor 488 F(ab’)2 goat anti-mouse IgG (H + L) secondary 
antibodies (green) during immunolocalization, whereas rhodamine (red)-labelled sm gDnA was used to detect sm nuclei during GIsH. 4,6-Diamidio-
2-phenylindole (blue) was used as a counter stain to identify both Bg and sm nuclei. scale bar, 2 µm. (d) msAP analysis of m5C in gDnA obtained 
from cercariae and adult worms. HpaII (filled shapes) and MspI (open shapes) isoschizomers were used to restrict mixed-sex adult worm (triangles) 
and cercariae (circles) gDnA samples. seven replicate samples were analysed for both schistosome life stages. msAP data is illustrated by principal 
coordinate analysis. HpaII loci enclosed by a dashed circle represent m5C identified in cercariae and HpaII loci enclosed by a solid circle represent m5C 
identified in adults.ARTICLE
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annotated schistosome genome (Supplementary Table S1). Confir-
mation of this genome prediction by PCR-based complementary   
DNA cloning (derived from adult female worm RNA) revealed the 
presence  of  two  alternatively  spliced  products  (GenBank,  acces-
sion numbers HM991456 and HM991457, differing by a 24 base 
indel).  Although  both  schistosome  transcripts  encoded  proteins 
containing conserved carboxy-terminal methyltransferase catalytic 
domains, they both lacked the extended amino-terminal regulatory 
regions found among metazoan Dnmt1 and Dnmt3 family mem-
bers29. With this observation in mind, we infer that the identified 
schistosome Dnmt orthologs are likely to be novel Dnmt2 family 
members30 (Supplementary Table S2). Therefore, we have named 
the protein products SmDnmt2 isoforms 1 and 2. Dnmt2 proteins, 
highly conserved across protists, plants, fungi and animals30, are 
enigmatic DNA methyltransferases as they can additionally har-
bour RNA methyltransferase activities31. Thus, in organisms that 
also contain the maintenance Dnmt1 and de novo Dnmt3 family 
members (for example, H. sapiens), Dnmt2 is not the primary DNA 
methyltransferase responsible for genome methylation32. However, 
in organisms that only contain a Dnmt2 ortholog, clear evidence 
from D. melanogaster23, D. discoideum27 and Entamoeba histolytica33 
indicates that these enzymes are relevant DNA methyltransferases. 
Pristionchus pacificus34 and Schizosaccharomyces pombe35 are notable 
exceptions to this rule as both organisms contain Dnmt2 orthologs, 
but lack a methylated genome. Deleterious mutations in the Dnmt2 
methyltransferase  catalytic  domains  are  sufficient  to  prevent 
genome methylation in these species. Therefore, the presence of a 
single DNA methyltransferase, containing a fully conserved meth-
yltransferase catalytic domain, in the schistosome genome implies 
that  this  enzyme  (SmDnmt2)  may  be  responsible  for  the  DNA 
methylation detected (Figs 1 and 2). This hypothesis was tested by 
post-transcriptional gene silencing (PTGS) of SmDnmt2 in adult 
worms (Fig. 3). Small interfering RNA (siRNA)-mediated PTGS of 
SmDnmt2 led to a 75% reduction in the amount of detectable tran-
script compared with control worms treated with siRNAs for luci-
ferase (Fig. 3a). The effect that SmDnmt2 knockdown had on global 
DNA methylation was subsequently assessed by MSAP analysis of 
adult worm gDNA and AMOVA (analysis of molecular variance)36. 
Worms treated with SmDnmt2 siRNA demonstrated a statistically 
significant (AMOVA analysis, P = 0.008) decreased epigenetic dis-
tance (ΦPT , solid histograms) among HpaII-digested populations 
(compared with luciferase siRNA control-treated worms) indicating 
a loss of DNA methyltransferase activity (Fig. 3b). The loss of dif-
ferential MSAP products (between isoschizomers) following SmD-
nmt2 silencing was clearly indicative of a widespread decline in 
genome-wide methylation (for example, arrow in Fig. 3c, retention 
of 209 bp HpaII gDNA peak in siSmDnmt2-silenced worms). Loss 
of m5C methylation within JF781495 (the methylated locus found 
in cercariae gDNA, Fig. 2) following SmDnmt2 silencing provides 
further evidence that the decline in global genome methylation is 
additionally observed within a specific locus targeted by the DNA 
methylation machinery (Fig. 3d). Low-level SmDnmt2 expression 
(25%) provides the most plausible explanation for the detection 
of  residual  methylation  (that  is,  differential  MSAP  loci  between 
isoschizomers or unaffected cytosine positions within JF781495) 
in siSmDnmt2-treated worms. Nevertheless, we contend that these 
PTGS experiments fully support the role of this gene product as a 
functional DNA methyltransferase. Additional SmDnmt2 activities, 
if any, are currently being sought.
A similar search was conducted for potential schistosome prod-
ucts  that  exhibited  sequence  similarity  to  methyl-CpG-binding   
domain  (MBD)  containing  proteins.  Instrumental  to  the  DNA 
methylation machinery, these proteins are recruited to methylated 
DNA sequences and are thought to associate with a range of inter-
acting  partners  to  mediate  transcriptional  regulation37.  BLASTp 
analysis of the schistosome genome with M. musculus MBD1 (NP_
038622) as the query sequence identified one candidate schistosome 
MBD, Smp_138180 (Supplementary Table S1; the only genome hit 
with E value  < 1e − 05). Subsequent PCR-based cDNA cloning of this 
candidate schistosome MBD ortholog (derived from adult female 
mRNA) revealed a single product (SmMBD, HM991455), encod-
ing a protein with an N-terminal methyl-binding domain and likely 
to be related to the conserved MBD2/3 ancestral protein38 (Supple-
mentary Table S3).
We hypothesized that if both SmDnmt2 and SmMBD were com-
ponents of a functional DNA methylation machinery they would 
be transcriptionally coregulated during schistosome development. 
Quantitative real-time reverse transcription PCR (qRT–PCR) analy-
sis of SmDnmt2 and SmMBD from schistosome lifecycle stages sup-
ported this hypothesis and indeed indicated coregulation of both 
transcripts during parasite development (Fig. 4a). Transcriptional 
regulation of SmDnmt2 mirrored the differential detection of m5C 
across the schistosome lifecycle (Fig. 1b) suggesting a direct link 
between the functional parasite gene product and this epigenetic mod-
ification. Furthermore, it was clear that both SmDnmt2 and SmMBD 
were  more  highly  expressed  in  intra-molluscan  developmental   
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Figure 2 | S. mansoni forkhead protein contains a highly methylated 
intragenic intron. (a) smp_155010 (ten exons—solid blocks, sequentially 
numbered and nine introns—black lines) is a predicted 37,170 bp gene 
encoding a forkhead protein found in scaff000180 of genome assembly 
4.0. A m5C enrichment protocol initiated with cercarial gDnA yielded a 
highly methylated 316 bp locus, nCBI accession number JF781495 (red box; 
mapping to a repetitive element-rich region spanning 24,803–25,119 bp of 
intron 8), found within smp_155010. (b) %GC representation of S. mansoni 
genomic elements containing the methylated locus. (c) Enumeration of 
m5C abundance (dinucleotide context percentages) in clones (n = 33) 
derived from bisulfite-PCR amplification of JF781495 after bisulfite 
cercarial gDnA conversion. The 42 cytosine positions within the 199-bp 
PCR product are indicated on the abscissa (5′–3′). solid line represents 
mean false m5C discovery rate (FDR) derived from control bisulfite 
reactions (methods) and dotted line represents mean FDR + 3×s.e.m. ARTICLE     
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forms when compared with intra-mammalian forms and that these 
genes were already abundantly transcribed in the infective cercar-
iae and miracidia lifecycle stages. It was also evident that sexually 
mature adult females expressed greater quantities of each transcript 
when  compared  with  sexually  mature  adult  males.  Importantly, 
measurement of nuclear DNA methyltransferase activity in adult 
females and males confirmed the SmDnmt2 transcriptional results 
obtained from this lifecycle stage (Fig. 4b), supported the differential 
detection of m5C between gender (Fig. 1b) and verified the nuclear 
localization  of  a  DNA  methyltransferase  activity  responsible  for 
m5C modifications in schistosomal cytological spreads (Fig. 1c).
Cytosine methylation regulates oviposition . We next wanted to 
determine whether there is a functional role for cytosine meth-
ylation during platyhelminth development. As eggs are primarily 
responsible for most pathological changes in infected individuals 
and are responsible for lifecycle transmission in endemic areas, we 
elected to examine the role of cytosine methylation in the impor-
tant process of schistosome oviposition. Moreover, linking cytosine 
methylation to egg production could provide valuable insights into 
this critical developmental process and crucially, identify useful tar-
gets for disease intervention strategies.
The  experimental  approach  chosen  involved  culturing  adult 
worm pairs for 48 h in the continuous presence of the DNA methyl-
transferase inhibitors, 5-azacytidine (5-AzaC, a ribonucleoside) and 
2′-deoxy-5-azacytidine (DAC or decitabine, a deoxyribonucleoside; 
Fig. 5)39. Both nucleoside analogues are integrated into replicating 
DNA where they form covalent bonds with Dnmts. This trapping of 
Dnmts triggers DNA damage signalling, Dnmt degradation and loss 
of methylation during subsequent rounds of DNA replication and 
cell division40. Whereas DAC preferentially incorporates into DNA, 
5-AzaC also becomes incorporated into newly synthesized RNAs41 
and can affect the synthesis/turnover of proteins42. Because of these 
nucleoside-specific characteristics and due to the fact that neither 
5-AzaC nor DAC have ever been tested on multi-cellular parasitic 
worms, it was first necessary to determine which compound was 
most effective in demethylating the adult schistosome genome. As 
both 5-AzaC and DAC are the FDA approved chemotherapies43 
used to induce selective toxicity in preleukemic bone marrow cells44, 
we first determined whether these nucleosides could directly kill 
adult schistosomes. Using bright-field microscopy and our recently 
developed helminth fluorescence bioassay45, we demonstrated that 
neither 5-AzaC nor DAC was lethal to adult worms (compared with 
controls),  even  when  drug  concentrations  reached  the  limits  of 
aqueous solubility (491 µM; Fig. 5a). Although toxicity may develop 
with time, this observation allowed us to examine the effect of both 
5-AzaC and DAC on cytosine methylation in viable adult schisto-
somes cultured for 48 h. Adult males, as opposed to adult females, 
were specifically chosen for this analysis because they do not contain 
m5C-rich egg gDNA (Fig. 1b, compare m5C levels in male, female 
and egg gDNA), which greatly simplified our interpretation of each 
nucleoside’s potential for reducing genomic cytosine methylation at 
the organism level. Using MSAP analysis of adult male gDNA and 
quantified by AMOVA, we show that 5-AzaC was more effective 
than DAC in decreasing epigenetic distance (ΦPT , solid histograms) 
among MspI- and HpaII-digested populations (Fig. 5b). Moreover, 
increased  epigenetic  variation  was  preferentially  detected  within 
5-AzaC-treated populations (ΦRT, open histograms) reflecting the 
random nature of methylation loss selectively induced by 5-AzaC 
(when compared with DAC) on the genomes in each cell of a multi-
cellular adult schistosome. Examples of MSAP HpaII loci affected 
by 5-AzaC, but not by DAC, are illustrated to support the AMOVA 
analysis (dashed arrows in Fig. 5c). On the basis of these results, 5-
AzaC was chosen as the nucleoside analogue for further analyses on 
parasite genome methylation and oviposition.
Further investigations into the ability of 5-AzaC ability to reduce 
methylation  of  the  schistosome  genome  revealed  a  clear  dose-
dependent effect (Fig. 6). Using MSAP analysis of adult male gDNA 
(free from host gDNA contamination, Fig. 6a) and quantified by   
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according to the methods section. (a) Quantitative real-time reverse 
transcription PCR (qRT–PCR) was used to assess the efficiency of smDnmt2 
silencing at 48 h post electroporation. All reactions were performed in 
triplicate (from biologically replicated samples, n = 2) and smDnmt2 
expression was normalized to α-tubulin, smAT1. Error bars represent the 
standard error of the normalized means (s.e.m.). Results are representative 
of three independent experiments. (b) AmoVA analysis of msAP profiles 
was used to assess the degree of CpG cytosine methylation loss after 96 h 
post electroporation (five biologically replicated male samples/siRnA 
treatment). Epigenetic variation between HpaII peaks derived from 
sismDnmt2-treated worms compared with HpaII peaks derived from 
siLuciferase-treated worms is statistically significant (AmoVA analysis, 
**P = 0.008). (c) Genemapper representation of an adult schistosome 
locus (arrow) where cytosine methylation is lost (loss of HpaII sensitivity) 
upon smDnmt2 silencing. MspI/HpaII represent the isoschizomers used to 
restrict gDnA before msAP analysis. (d) Enumeration of m5C abundance 
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PCA (Fig. 6b) and AMOVA (Fig. 6c), increasing concentrations of 
5-AzaC (0, 10 and 491 µM) led to a decrease in epigenetic distance 
(ΦPT, solid histograms) among MspI- and HpaII-digested popula-
tions. In addition, increased epigenetic variation was also detected 
within  treated  populations  (ΦRT,  open  histograms)  reflecting  the 
dose-dependent  random  nature  of  methylation  loss  induced  by   
5-AzaC.
Having demonstrated that 5-AzaC inhibits cytosine methylation 
in adult schistosomes (Figs 5 and 6), we next investigated whether 
deficiencies  in  this  epigenetic  process  affected  egg  production, 
egg phenotype, egg maturation and ovarian morphology (Fig. 7). 
Treatment of adult worm pairs with 5-AzaC led to a reduction in 
female egg output over a 48-h period when compared with control 
worms (Fig. 7a) or worm pairs treated with DAC (Supplementary 
Fig. S1). This observation was dose dependent, correlated to the 
degree of genome demethylation (Figs 5 and 6) and statistically 
significant even when 5-AzaC concentrations were as low as 10 µM. 
Although eggs laid by control female worms were phenotypically 
normal (oval, presence of a lateral spine, regular auto-fluorescence 
due  to  eggshell  tanning46  and  ~150 µm  in  length),  eggs  laid  by   
5-AzaC-treated females displayed a broad range of phenotypic abnor-
malities (Fig. 7b). These abnormal eggs included individuals that 
c
Control
DAC
5-AzaC
W
o
r
m
 
t
r
e
a
t
m
e
n
t
MspI (MSAP isoschizomer)
Length (bp)
300 305
300 305
300 305
Control
DAC
5-AzaC
W
o
r
m
 
t
r
e
a
t
m
e
n
t
HpaII (MSAP isoschizomer)
Length (bp)
300 305
300 305
300 305
100
80
60
40
20
0
Control 5-AzaC
(491 µM)
DAC
(491 µM)
%
 
V
i
a
b
i
l
i
t
y
a
b
Control 5-AzaC
(491 µM)
DAC
(491 µM)
0.9
0.7
0.5
0.3
0.1
E
p
i
g
e
n
e
t
i
c
 
v
a
r
i
a
t
i
o
n
ΦPT Inter-population 
distance
ΦRT Intra-population 
distance
Figure 5 | Schistosome cytosine methylation is affected by 5-azacytidine 
(5-AzaC) but not decitabine (DAC). (a) The helminth fluorescent 
bioassay indicated that neither 5-AzaC nor DAC was toxic to adult 
male schistosomes (open histogram—% mean viability of control adult 
worms; filled histogram—% mean viability of adult worms treated with 
either 491 µm 5-AzaC or 491µm DAC). Error bars represent standard 
error of the normalized % viability mean (s.e.m.) collected from three 
individual worms. (b) AmoVA analysis of msAP profiles was used to 
assess the degree of cytosine methylation loss after 48 h treatment with 
5-AzaC (n = 4 adult male biological replicates) and DAC (n = 4 adult male 
biological replicates) compared with controls (n = 4 adult male biological 
replicates). (c) Genemapper representation of two adult male schistosome 
loci (dashed arrows) where CpG cytosine methylation is lost (loss in HpaII 
sensitivity) upon 5-AzaC, but not DAC, treatment. MspI/HpaII represent 
the isoschizomers used to restrict gDnA before msAP analysis.
S
m
D
n
m
t
2
 
e
x
p
r
e
s
s
i
o
n
 
r
e
l
a
t
i
v
e
 
t
o
 
S
m
A
T
1
S
m
M
B
D
 
e
x
p
r
e
s
s
i
o
n
 
r
e
l
a
t
i
v
e
 
t
o
 
S
m
A
T
1
Miracidia
Mother
sporocysts
Daughter
sporocysts
Cercariae
48 h
Schistosomula
4-week Mixed
sex adults
7-week Males
7-week Females
SmDnmt2
SmMBD
Intra-molluscan Intra-mammalian
0.015
0.005
0.000
0.010
0.020
0.025
0.160
0.120
0.080
0.200
0.040
0.000
**
**
a
b 300,000
0
100,000
200,000
35,000
25,000
5,000
15,000
D
n
m
t
1
 
a
c
t
i
v
i
t
y
 
(
R
F
U
,
 
p
o
s
i
t
i
v
e
 
c
o
n
t
r
o
l
)
D
n
m
t
 
a
c
t
i
v
i
t
y
(
R
F
U
,
 
s
c
h
i
s
t
o
s
o
m
e
 
n
u
c
l
e
i
 
a
n
d
 
n
e
g
a
t
i
v
e
 
c
o
n
t
r
o
l
)
Dnmt1
7-week Females
7-week Males
*
Figure 4 | SmDnmt2 and SmMBD are transcriptionally coregulated 
during schistosome development. (a) qRT–PCR determination of 
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methyltransferase activity (negative control). Left ordinate scale represents 
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lacked lateral spines, were often much smaller than controls (as small   
as 50 µm), were spherical rather than oval and were not fully hard-
ened or tanned (irregularly autofluorescent). Eggs displaying more 
than one of these phenotypes were the norm and were additionally 
observed within the uterus (Fig. 7c), which indicated that 5-AzaC’s 
inhibition of cytosine methylation had disrupted several vital com-
ponents of the schistosome oviposition pathway.
After establishing that there is an important role for cytosine 
methylation  in  normal  egg  output/phenotype,  we  investigated 
whether this epigenetic process regulated the in vitro developmental 
maturation of newly deposited eggs (Fig. 7d). According to the stag-
ing classification of Michaels and Prata47, schistosome eggs undergo 
a  process  of  in  vitro  development  involving  five  discrete  forms 
(stages I–V; representative stage I + II, stage III–V and hatched eggs 
are illustrated in Fig. 7d). Although development of eggs proceeded 
normally in control wells over a 6-day period, egg maturation was 
markedly  impaired  in  wells  containing  5-AzaC.  Very  few  eggs 
released miracidia (3% hatched eggs compared with 16% found in 
control wells) and most (~70% compared with 33% found in con-
trol wells) never progressed past stage I + II (embryonic disk occu-
pying one half of the diameter of the egg). Together, these results 
firmly indicated that cytosine methylation also influences normal 
egg developmental progression and, thus, probably has a significant 
role in schistosomiasis transmission.
Finally, our attention was drawn to the effect that 5-AzaC had on 
ovarian morphology within cultured female schistosomes (Fig. 7e).   
S. mansoni females each contain one ovary, where small, poorly 
differentiated  immature  oocytes  develop  into  well-differentiated 
mature oocytes along an anterior to posterior gradient. Whereas   
this organization was consistently observed in control female worms, 
5-AzaC-treated females contained reproducible gross-morphologi-
cal defects including numerous large inter-mo vacuoles, atypical 
dendritic-like process extending into the vacuoles and a complete 
breakdown in normal ovarian architecture. Although we have yet to 
determine how these abnormalities influence zygote formation and 
egg production, we contend that cytosine methylation and SmD-
nmt2 are instrumental in the uniform gradient of oocyte develop-
ment within the ovary and mo release into the oviduct. Together 
with a role in eggshell tanning, egg production and maturation, our 
results strongly suggest that cytosine methylation participates in 
most major aspects of schistosome oviposition.
Discussion
Less than 3 years after the S. mansoni genome was reported28 and 
10 years after the failure to detect DNA methylation8, a functional 
role for m5C modifications during oviposition has been established 
(Fig. 7). This discovery represents a significant advance in our under-
standing  of  platyhelminth  biology.  Additional  findings  reported 
herein that illustrate a clear link between m5C abundance (Fig. 1) 
and SmDnmt2 developmental expression (Fig. 4) suggest an auxil-
iary role for the schistosome DNA methylation machinery in transi-
tioning between free-living and parasitic life styles, worm maturation 
within the definitive mammalian host and sporocyst asexual proc-
esses (for example, multiplication of infective stage cercariae) within 
the intermediate snail host. Further mechanistic studies into how 
this particular epigenetic modification is influenced by diverse envi-
ronmental stimuli (water, intermediate or definitive hosts) may ulti-
mately shed new light on the fine nuances of host/parasite cross talk 
including orchestration of successful survival strategies, development 
of extended phenotypes and the induction of appropriate danger sig-
nals. The identification of all genomic loci differentially methylated 
during schistosome development (in addition to the single methyl-
ated locus found herein, Fig. 2) will help in this endeavour.
Although we do not yet have an explanation for why 5-AzaC is 
more effective than DAC in reducing schistosome genome methyla-
tion (Fig. 5), it is likely that the differential ability of these two nucleo-
side analogues to cross the parasite’s outer heptalaminate membrane48 
or the differential stability of each during the in vitro cultivation 
period40,49 may be responsible. Nevertheless, our data suggest that 5-
AzaC is a stable inhibitor of DNA methyltransferase activity and is 
capable of inhibiting native SmDnmt2 (the only bona fide functional 
DNA methyltransferase in the schistosome genome, Supplementary 
Table S2; Fig. 3) during in vitro schistosome cultivation. Whether 5-
AzaC or SmDnmt2 also affect schistosome RNA methylation31,50 is 
currently unknown, but is the subject of ongoing investigations.
We envisage that the discovery of this epigenetic alteration within 
an  ancient  invertebrate  lineage  will  drive  future  investigations 
aimed at deciphering its contrasting and overlapping roles during 
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Figure 6 | 5-Azacytidine inhibits S. mansoni DNA methylation in a  
dose-dependent manner. (a) Adult schistosome gDnA isolated from 
adult male worm cultures (control, 10 µm 5-AzaC and 491 µm 5-AzaC) 
were examined for the presence of M. musculus gDnA contamination by 
PCR before msAP analyses. Primers designed to amplify M. musculus (mm) 
catalase and S. mansoni (sm) Venom Allergen Like (VAL) 2 were used. 
mm catalase primers only amplified a product (sequence verified catalase, 
653 bp, solid arrow) when mm gDnA was used as a template. smVAL2 
primers only amplified a product (sequence verified smVAL2, 291 bp, 
dashed arrow) when sm gDnA was used as a template. ( − ) represents PCR 
conditions when no gDnA was included in the reaction and mW represents 
molecular weight standards. (b) msAP analysis of m5C in gDnA obtained 
from 5-AzaC-treated adult male worms. HpaII (open shapes) and MspI 
(filled shapes enclosed by dashed circle) isoschizomers were used to restrict 
adult worm gDnA from control samples (squares), 10-µm 5-AzaC-treated 
samples (triangles) and 491-µm 5-AzaC-treated samples (circles). Five 
biological replicates were analysed for all treatments/enzyme combinations. 
The dose-dependent demethylating ability of 5-AzaC is illustrated by 
principal coordinate analysis. (c) statistical assessment of msAP profiles by 
AmoVA. significant differences (P < 0.01) in epigenetic variation are found 
between populations (ΦPT; HpaII-MspI inter-population distances between 
controls, 10 µm- and 491 µm-5-AzaC samples) and within populations  
(ΦRT; HpaII intra-population distances among controls compared with HpaII 
intra-population distances among 5-AzaC-treated worms).ARTICLE
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metazoan evolution. Perhaps, more importantly in the context of 
schistosomiasis control, our results demonstrate that targeting para-
site cytosine methylation components with selective demethylating 
agents present a promising new avenue through which to combat a 
major human neglected tropical disease.
Methods
Parasite cultivation and gDNA isolation. A Puerto Rican strain of S. mansoni 
was used in this study. All procedures performed on mice (6- to 7-week-old female 
Tuck Ordinary and C57BL/6 strains; Harlan, UK) adhered to the United Kingdom 
Home Office Animals (Scientific Procedures) Act of 1986 and were approved by 
Aberystwyth University’s Ethical Review Panel. Parasite material was obtained 
as previously described6. When necessary, adult worms and schistosomula were 
cultured at 37 °C in DMEM supplemented with 10% foetal calf serum, 2 mM 
l-glutamine and 100 mg ml − 1 penicillin/streptomycin in an atmosphere of 5% CO2 
for up to 48 h with a 70% media exchange performed after 24 h. Genomic DNA 
was isolated from parasite material using the Qiagen DNeasy Blood and Tissue Kit 
(Qiagen), with contaminating RNA eliminated using an RNase cocktail.
GC–MS identification of m5C. Derivatization of mixed-sex adult worm m5C and 
detection of m5C derivative by GC–MS was performed according to Crain51 using 
a HP-1 MS GC column. Briefly, MS data were acquired using an Agilent 5973N 
GC/MS instrument (Agilent) operated in the selected ion-monitoring mode. The 
tert-butyldimethylsilyl m5C derivative was detected by measuring the intensity of 
the selected ion (m/z = 296.2) throughout the GC run.
5-AzaC and decitabine treatment of S. mansoni adults. Adult worms were 
cultured at a density of ten worms (five male/female pairs or ten individuals of the 
same gender) per well in 1 ml of media and different concentrations of 5-AzaC or 
decitabine (DAC; Sigma-Aldrich). Each condition was performed in quadruplicate 
with the experiment replicated three to five times. After 48 h, the adult worms were 
removed, gender separated (if necessary), their viability determined and gDNA 
prepared for m5C detection. In wells containing adult worm pairs, the eggs were 
counted and subsequently subjected to laser confocal imaging.
ELISA detection of m5C. Cytosine methylation was fluorescently detected in  
S. mansoni gDNA samples (100 ng) using the DNA SuperSense Methylated DNA 
Quantification assay (Epigentek) following the manufacturer’s instructions. 
Fluorescent values obtained from the negative DNA control sample (containing 0% 
m5C) were subtracted from the fluorescent readings obtained for all of the schisto-
some gDNA samples as well as the positive DNA control samples (containing 100% 
m5C). The adjusted fluorescence detected in the positive DNA control sample was 
now set to 100% (maximal detected m5C) and m5C abundance in each schisto-
some lifecycle stage was normalized to this value and depicted as a percentage.
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m5C immunolocalization and GISH of cytological preparations. Cytological 
spreads were prepared from intra-molluscan parasites52. Slides, containing both 
Schistosoma and Biomphalaria nuclei, were incubated overnight at 4 °C with mouse 
anti-m5C primary Ab (Calbiochem, Clone 162 33 D3) or nonspecific anti-mouse 
IgG1 (Invitrogen). GISH, to distinguish Schistosoma nuclei, was subsequently 
performed according to Hasterock et al.53 Slides were finally incubated for 2 h at 
room temperature with Alexa Fluor 488 conjugated goat anti-mouse IgG secondary 
antibody (Invitrogen). Cytological spreads were counterstained with diamidio-2-
phenylindole.
MSAP analysis of S. mansoni CpG methylation. To compare cytosine methyla-
tion patterns between schistosome samples, an AFLP (amplified fragment length 
polymorphism) protocol developed by Vos et al.54 and modified for methylation 
analysis by Reyna-Lopez et al.22 was employed. Each study used the isoschizomers 
HpaII and MspI as well as EcoRI. For lifecycle studies, seven mixed-sex adult- and 
cercarial-gDNA samples were used; for comparative drug studies, four adult male 
samples were used per condition (491 µM DAC, 491 µM 5-AzaC and controls); for 
5-AzaC titration studies, five adult male samples were used for each condition  
(0, 10 and 491 µM 5-AzaC); for siRNA studies, five adult male samples were used 
for each treatment (siDnmt2- and siLuciferase-treated worms). Sample fraction-
ing of fluorescently labelled MSAP products was performed on an ABI 3100 
DNA Fragment Analyzer. Pairwise FST (genetic variance among populations) 
and AMOVA36 were subsequently calculated using GenAlex (v.6.4) to analyse the 
proportion of variance distributed among and within samples as well as to test 
the significance of FST between samples55. The probability of non-differentiation 
(FST = 0) was estimated over 9,999 permutations (Fig. 3b).
Measurement of DNA methyltransferase activity. DNA methyltransferase 
activity was measured in nuclear protein extracts processed from adult male and 
female worms cultured in vitro for 48 h. An EpiQuik™ Nuclear Extraction Kit I 
(Epigentek) was used to prepare the adult worm nuclear protein extracts while an 
EpiQuik DNA Methyltransferase Activity/Inhibition Kit (Epigentek) was used to 
quantify DNA methyltransferase activity.
Methylated gDNA locus identification. Methylated fragment enrichment (origi-
nating with cercariae gDNA) was performed using the Methylminer Methylated 
DNA Enrichment Kit (Invitrogen) according to the manufacturer’s instructions. 
After sequencing 35 randomly chosen clones and mapping to the S. mansoni 
genome (assembly 4.0), one locus was selected (deposited under NCBI accession 
number JF781495, mapping to intron eight of Smp_105510; scaffold000180 posi-
tion 213,627—213,942 bp) for methylation status confirmation by sodium bisulfite 
conversion using the BisulFlash DNA Modification Kit (Epigentek). Bisulfite PCR 
primers (Supplementary Table S4, designed using Methyl Primer Express v. 1.0, 
http://www.appliedbiosystems.com/) were used to amplify a 199 bp fragment of 
JF781495 from converted gDNA samples. Purified PCR products were cloned us-
ing the TOPO TA Cloning Kit (Invitrogen) and 33 clones subsequently sequenced, 
aligned and analysed for their methylation status. Cytosine methylation of this lo-
cus in adult samples was additional performed as part of the siRNA manipulations.
Calculation of sodium bisulfite conversion efficiency. Sodium bisulfite conver-
sion efficiency was calculated using a non-methylated DNA control (741-bp PCR 
product derived from Smp_121930.1, NCBI accession number XM_002571391). 
This control sample was added to schistosome gDNA samples (derived from siRNA 
experiments) before sodium bisulfite conversion. Bisulfite-PCR amplification of 
the control sample after conversion generated a 386 bp amplicon (53 cytosines in 
the parent DNA molecule between bisulfite primer-binding sites; primer sequences 
found in Supplementary Table S4). Sequence analysis of the purified clones (n = 18) 
facilitated the quantification of sodium bisulfite conversion efficiency (93.5 and 
93.3% in two independent reactions). Therefore, an average bisulfite conversion 
efficiency of 93.4% and a false positive m5C detection rate of 6.6% were detected 
in this study. Accordingly, we only report the C positions (and their dinucleotide 
context) within bisulfite-converted JF781495 that have a 6.9% non-conversion rate 
(mean false positive discovery rate + 3×s.e.m.). These Cs represent the most likely 
methylated positions within the parent JF781495 sequence.
RNA isolation and RT–PCR analysis. S. mansoni total RNA isolation and  
qRT–PCR analyses was performed as previously described6,56. Briefly, all schisto-
some lifecycle stages used for qRT–PCR analysis were derived from cDNA 
reactions initiated by 1-µg total RNA (obtained from each profiled or siRNA 
manipulated lifecycle stage). Reverse transcriptase-negative control reactions were 
included in each experiment to account for gDNA contamination. All qRT–PCR 
amplifications were performed in triplicate using Fast SYBR Green chemistry and 
a StepOnePlus thermocycler (Applied Biosystems). qRT–PCR primers (sequences 
found in Supplementary Table S4), spanning introns where possible, were used 
for amplifying SmDnmt2 and SmMBD. SmDnmt2 and SmMBD gene expression 
results were independently normalized to α-tubulin (SmAT1, primer sequences 
found in Supplementary Table S4), a constitutively expressed house-keeping gene6.
siRNA mediated SmDnmt2 silencing. siRNAs, spanning the coding region 
of SmDnmt2 at positions 351–376 bp, were used to silence SmDnmt2. siRNAs 
designed for firefly luciferase functioned as a negative control. For each siRNA 
treatment, five adult worm pairs were electroporated as described elsewhere57.  
Each experimental condition was performed in duplicate and RNA was isolated 
from adult worm pairs after a 48 h in vitro culture period (see above). SmDnmt2 
silencing was then assessed by qRT–PCR from technical triplicates as described 
above. To investigate whether SmDnmt2 silencing led to a loss in genome  
methylation, gDNA from siRNA-treated worm pairs (siSmDnmt2 and siLuciferase, 
five biological replicates for each) were isolated after a 96-h in vitro culture and 
MSAP analysis performed as described above.
Viability assay. The helminth fluorescent bioassay developed by Peak et al.45 was 
used to assess the viability of adult schistosomes treated with 5-AzaC and DAC 
(at 491 µM). Three adult male schistosomes were used for each experimental 
manipulation.
Assessment of egg development. Adult worm pairs were removed from control 
and 5-AzaC-treated (100 µM) cultures after 48 h and the produced eggs were left to 
develop for a further 4 days. On day 6, eggs were transferred to artificial river water 
and exposed to a light source for 2 h to induce hatching. Afterwards, all material was 
fixed in 10% buffered formalin, enumerated and categorized into four groups accord-
ing to their state of maturation47: stage I + II, stage III–V, hatched egg and unidentified.
Carmine staining of adult female schistosomes. Adult female worms were fixed 
in AFA (48% alcohol, 25% formalin, 2% acetic acid) and stained with Langeron’s 
Carmine as previously described58. Parasite material was cleared with xylene and 
worms subsequently mounted with DPX (distyrene, plasticiser, xylene) before 
confocal microscopy.
Confocal laser microscopy. Carmine stained adult female worms and schistosome 
eggs deposited in vitro were examined with a Leica TCS SP5II confocal micro-
scope. A ×40 immersion lens, a 488-nm argon laser and a 561-nm diode-pumped, 
solid state (DPSS) laser were used to examine the adult female worms. Eggs were 
fixed in 10% saline-buffered formalin and examined using a ×63 oil immersion lens 
and a 488-nm argon laser. 
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